For example, exome-sequencing studies found that SF3B1 was mutated in 10–15% of patients with chronic lymphocytic leukemia, while other spliceosome genes (e.g. SRSF1, SRSF7 and U2AF65) were mutated at lower (but still detectable) frequencies in chronic lymphocytic leukemia patients [12, 13]. This evidence concerns the gene U2AF2 and B-cell chronic lymphocytic leukemia.